Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
76.15 CHF | +1.13% | +6.32% | +48.72% |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day | |
Mar. 20 | Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.72% | 1.32B | |
+25.61% | 660B | |
+24.05% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.49% | 219B | |
-9.73% | 196B | |
+6.85% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals N : to Receive $6 Million Milestone Payment from Acacia on First US Sale of Byfavo